Press Releases

All Releases
View Summary Ophthotech Reports Fourth Quarter and Full Year 2015 Financial and Operating Results
Feb 24, 2016
PDF 24.2 KB Add to Briefcase
View Summary Ophthotech Corporation to Present at RBC Capital Markets Healthcare Conference
Feb 18, 2016
PDF 10.5 KB Add to Briefcase
View Summary Ophthotech Corporation to Report Fourth Quarter 2015 Financial Results and Host Conference Call on Wednesday, February 24, 2016
Feb 17, 2016
PDF 11.1 KB Add to Briefcase
View Summary Ophthotech Corporation to Present at the LEERINK Partners 5th Annual Global Healthcare Conference
Feb 3, 2016
PDF 10.5 KB Add to Briefcase
View Summary Ophthotech Announces First Patient Dosed in Zimura® Phase 2/3 Study to Evaluate Treatment in Patients with Geographic Atrophy, an Advanced Form of Dry Age-Related Macular Degeneration
Jan 27, 2016
PDF 12.0 KB Add to Briefcase
View Summary Ophthotech Announces Appointment of David E. Redlick to Its Board of Directors
Jan 6, 2016
PDF 12.4 KB Add to Briefcase
View Summary Glenn P. Sblendorio to Join Ophthotech as Executive Vice President, Chief Operating Officer and Chief Financial Officer
Jan 5, 2016
PDF 16.5 KB Add to Briefcase
View Summary Ophthotech Corporation to Present at the 34th Annual J.P. Morgan Healthcare Conference
Jan 4, 2016
PDF 10.4 KB Add to Briefcase
View Summary Ophthotech Corporation to Present at the Oppenheimer 26th Annual Healthcare Conference
Dec 2, 2015
PDF 10.6 KB Add to Briefcase
View Summary Ophthotech Corporation to Host R&D Investor Day on December 3, 2015
Dec 1, 2015
PDF 10.7 KB Add to Briefcase
View Summary Ophthotech Announces that Genentech, a Roche Wholly-Owned Subsidiary, Elects to Exercise Its Right to Opt-in to the Novartis Portion of the Ophthotech / Novartis Ex-US Agreement for Fovista® to Treat Wet Age-Related Macular Degeneration
Nov 17, 2015
PDF 18.4 KB Add to Briefcase
View Summary Ophthotech Corporation to Present at the 2015 Stifel Healthcare Conference
Nov 12, 2015
PDF 10.6 KB Add to Briefcase
View Summary Ophthotech Reports Third Quarter 2015 Financial and Operating Results
Nov 5, 2015
PDF 23.0 KB Add to Briefcase
View Summary Ophthotech Corporation to Report Third Quarter 2015 Financial Results and Host Conference Call on Thursday, November 5, 2015
Nov 2, 2015
PDF 11.2 KB Add to Briefcase
View Summary Ophthotech Completes Patient Recruitment of the Second Phase 3 Pivotal Trial of Fovista® Anti-PDGF Therapy in Combination with Lucentis® in Wet Age-Related Macular Degeneration
Oct 26, 2015
PDF 14.1 KB Add to Briefcase
View Summary Ophthotech Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Sep 2, 2015
PDF 10.5 KB Add to Briefcase
View Summary Ophthotech Reports Second Quarter 2015 Financial and Operating Results
Aug 5, 2015
PDF 23.0 KB Add to Briefcase
View Summary Ophthotech Corporation to Report Second Quarter 2015 Financial Results and Host Conference Call on Wednesday, August 5, 2015
Jul 29, 2015
PDF 11.2 KB Add to Briefcase
View Summary Ophthotech Announces New Senior Leadership Appointments
Jul 21, 2015
PDF 15.4 KB Add to Briefcase
View Summary Ophthotech Corporation to Present at the Goldman Sachs 36th Annual Global Healthcare Conference
Jun 3, 2015
PDF 10.8 KB Add to Briefcase
Showing 21-40 of 89 Page: 1 2 3 4 5  Previous 20 | Next 20
Showing 21-40 of 89
Page: 1 2 3 4 5
 Previous 20 | Next 20
Add to Briefcase = add release to Briefcase